Oxford BioTherapeutics

📍 Oxford, United Kingdom🗓 Founded 2004👥 51 employees💰 Last funded Jul 2018
Biotechnology🌐 oxfordbiotherapeutics.com
Website LinkedIn
Oxford BioTherapeutics (OBT) is a clinical stage oncology company based in Oxford, UK; San Jose, CA and Morristown, NJ, USA, with a pipeline of first-in-class immuno-oncology (IO) and antibody-drug conjugate (ADC) based therapies designed to fulfil major unmet patient needs in cancer therapeutics. Our lead asset, OBT076, is an Antibody Drug Conjugate (ADC) in Phase 1b clinical development. OBT076s dual mechanism of action allows it to act as a primer to re-engage the patients immune system while at the same time targeting cancer cells directly. OBT’s proprietary OGAP® target discovery platform is based on one of the world’s largest proprietary cancer membrane proteomic databases, with data on over 5,000 cancer cell proteins providing unique, highly qualified oncology targets, of which three programs are in clinical development in the USA and Europe. The company’s pipeline and development capabilities have been validated through multiple strategic partnerships, including with Boehringer Ingelheim, ImmunoGen and Kite Pharma as well as other world leaders in antibody development (such as Amgen, WuXi, Medarex (BMS), Alere (Abbott)).
3
Total investors
0
Early stage
0
Mid stage
0
Late stage
2004
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United States
1
Hong Kong SAR
1
United Kingdom
1
Investor activity2015–2018 · investors recorded per year
201512016120181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Oxford BioTherapeutics?
Oxford BioTherapeutics has 3 investors on record on gritt.io.
When did Oxford BioTherapeutics last raise funding?
The most recent investment in Oxford BioTherapeutics recorded on gritt.io was in July 2018.
When was Oxford BioTherapeutics founded?
Oxford BioTherapeutics was founded in 2004.
What industry is Oxford BioTherapeutics in?
Oxford BioTherapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Oxford BioTherapeutics based?
Oxford BioTherapeutics is headquartered in Oxford, United Kingdom.